Tudor Health brings together senior patient-level data expertise and agentic AI to create a different approach to capturing, processing and delivering patient-level intelligence.
Tudor Health was founded in 2021 to close gaps in commercial patient data, particularly in oncology and rare diseases. Following a period of research, development and proof-of-concept testing, Tudor began commercial operations in 2023.
Our approach combines tried and tested patient-level research methods with innovations in data capture, sampling, processing, analysis and delivery.
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. This gives us the opportunity to gradually expand the extent of the data held on each patient, which gives us greater depth of analytical options.
Tudor Data provides a representative view of the population in scope alongside detailed patient histories and ongoing management. Targeted sampling can bring rare, niche or priority patient groups into clearer view.
Our HCP-led approach can be applied across disease areas, specialties, care settings and markets, supporting more consistent and comparable patient-level evidence.
Our programmes support Early Pipeline, Commercial Assessment, Marketing, Medical Affairs, Market Access and Insights teams. Senior specialists remain directly involved in the methodology, quality and interpretation.
Nimbus© connects programme design, capture, fieldwork, quality control, processing, analysis and delivery. Agentic AI supports defined, repeatable activities across the workflow.
By following the same HCPs and patients over time, Tudor helps clients measure change rather than infer it. Live dashboards and analysis keep the full dataset available as new questions emerge.
Nimbus© handles repeatable production activity, while Tudor’s senior specialists remain accountable for the decisions and outputs that matter. The result is richer patient-level evidence, greater continuity and faster access to decision-ready insight.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
The Tudor Health data model uses an identical data-capture method in all countries. This makes the data consistent within country and comparable across countries.
Tudor Health is led by Simon Fitall, our founding CEO
Simon is an accomplished executive with a deep understanding of data and data analytics and a passion for educating others. His career started at A.C. Nielsen, progressed to OTC product management, and later into market research with Taylor Nelson. Simon founded Marketing Resources International, specializing in data analytics, modelling, and forecasting. This venture marked the beginning of his public speaking engagements, journal publications, and training courses aimed at enhancing knowledge and skills in the field of data analytics.
During his tenure at MRI, Simon honed his skills in quantitative and qualitative research techniques, working with leading pharmaceutical and biotech companies to create analytical market models. This role evolved into a co-founder position at Galileo Analytics, a company focused on visualising and analysing health data. As CEO of health data start-up Tudor Health, Simon continues to break new ground, creating innovative data capture, analysis, and delivery models. He is also the CEO of Galileo Analytics and has pioneered tools to support various areas of healthcare, including drug and device development. In addition to running multiple training programs for various organisations, Simon has had numerous papers, publications, and workshops published. He also served as the editor of the first edition of the University of Georgia/MRII online training program for Pharmaceutical Marketing Research. Simon’s experience, innovation, and dedication to education are underpinned by a relentless pursuit of knowledge and a commitment to sharing this knowledge for the benefit of others. Simon lives in France and is a very keen walker and photographer
We explore a case study where patient-level EMR-equivalent data was collected from institutions that are…
In this brief paper we outline two areas of PLD where the Tudor Health methods…
There has been increased discussion in the USA in the past week regarding…